Jayamas Medica Industri Tbk.

OMED · Kesehatan · Jasa & Peralatan Kesehatan

200

+1.01% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 63

  • Value

    41Against 788 other IDX companies

    Priced about in line with comparable stocks.

    P/E
    13.8×
    59%Cheaper than 59% of other IDX companies
    P/B
    1.92×
    32%Cheaper than 32% of other IDX companies
    Dividend yield
    1.8%
    32%Higher than 32% of other IDX companies
  • Quality

    83Against 788 other IDX companies

    Among the most profitable of comparable stocks.

    Return on equity
    13.9%
    78%Higher than 78% of other IDX companies
    Return on assets
    11.9%
    89%Higher than 89% of other IDX companies
    Net margin
    17.9%
    83%Higher than 83% of other IDX companies
  • Growth

    63Against 788 other IDX companies

    Growing faster than most comparable stocks.

    Profit, last 4 quarters
    +18.6%
    59%Higher than 59% of other IDX companies
    Profit, 3-year yearly
    +8.7%
    56%Higher than 56% of other IDX companies
    Profit, latest quarter vs a year ago
    +35.2%
    62%Higher than 62% of other IDX companies
    Revenue, latest quarter vs a year ago
    +31.2%
    73%Higher than 73% of other IDX companies
  • Momentum

    72Against 836 traded stocks

    Has done better than most stocks over the past year.

    1-year price change
    +1.5%
    72%Better than 72% of traded stocks
  • Liquidity

    64Against 836 traded stocks

    Trades more than most IDX stocks.

    Value traded per day, 30 days
    IDR 2.9B
    64%Higher than 64% of traded stocks
  • Retail penalty

    −2Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 33% of the other stocks where it is, so 2 points come off the rating.

    Retail average buy
    228
    Close vs that average
    -12.3%
    Retail net bought
    -282K lots

Similar stocks

Rated most like OMED across the five pillars. Change is over the past year.